Screener
ADMA Biologics ADMA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| COMMITMENTS AND CONTINGENCIES | ||
| STOCKHOLDERS' EQUITY | ||
| Preferred Stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding | - | - |
| Common Stock - voting, $0.0001 par value, 300,000,000 shares authorized,June 30, 2026: 241,089,992 issued and 225,355,228 outstanding;December 31, 2025: 239,793,566 issued and 237,874,496 outstanding | 24 | 24 |
| Treasury stock, at cost, 15,734,764 and 1,919,070 shares as of June 30, 2026 and December 31, 2025, respectively | (188,452) | (32,090) |
| Additional paid-in capital | 675,139 | 671,039 |
| Accumulated deficit | (78,503) | (161,653) |
| TOTAL STOCKHOLDERS' EQUITY | 408,208 | 477,320 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's common stock?
- ADMA Biologics (ADMA) reported common stock of 300M in Q2 2026.
- How has ADMA Biologics's common stock changed year-over-year?
- ADMA Biologics's common stock decreased by 0.0% year-over-year, from 300M to 300M.
- What is the long-term trend for ADMA Biologics's common stock?
- Over 5 years (2020 to 2025), ADMA Biologics's common stock has grown at a 678.5% compound annual growth rate (CAGR), from 10.5K to 300M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about ADMA Biologics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude